Brief: Better Therapeutics Reports Fourth Quarter And Full Year 2022 Financial Results

Better Therapeutics

30/03/2023 12:36

March 30 (Reuters) - Better Therapeutics Inc  BTTX.O :
    * BETTER THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR
2022
FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATES
    * ADVANCED PREPARATIONS FOR POTENTIAL COMMERCIAL LAUNCH OF
BT-001
IN U.S. IN MID-2023
    * ANNOUNCED RESTRUCTURING AND OTHER COST SAVING ACTIONS TO
EXTEND
FINANCIAL RUNWAY
    * CASH AND CASH EQUIVALENTS WERE $15.7 MILLION ON DECEMBER
31,
2022
    * BETTER THERAPEUTICS - AS RESULT OF RESTRUCTURING, EXPECT
OPERATING CASH BURN FOR 2023 TO BE LOWER THAN PREVIOUSLY
FORECASTED BY ABOUT $10 MILLION
    * QTRLY LOSS PER SHARE $0.37
    * Q4 EARNINGS PER SHARE VIEW $-0.51 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nBw4Mk0Wba 
Further company coverage:  BTTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))